|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/40 | (2006.01) |
| A61K 31/436 | (2013.01) | ||
| A61P 9/12 | (2006.01) | ||
| A61P 9/12 | (2018.01) |
| (11) | Number of the document | 3821891 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20211109.2 |
| Date of filing the European patent application | 2012-04-30 | |
| (97) | Date of publication of the European application | 2021-05-19 |
| (45) | Date of publication and mention of the grant of the patent | 2023-06-07 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201161481317 P | 2011-05-02 | US |
| (72) |
SPIEKERKOETTER, Edda , US
RABINOVITCH, Marlene , US
BEACHY, Philip, A. , US
SOLOW-CORDERO, David , US
|
| (73) |
The Board of Trustees of the Leland Stanford
Junior University ,
Office of the General Counsel
Building 170, Third Floor, Main Quad
P.O. Box 20386, Stanford, CA 94305-2038,
US
|
| (54) | USE OF FK506 FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION |
| USE OF FK506 FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION |